compname says qtrly sales grew num-four% to $num-one billion.
qtr-three earnings per share was $num-one.
full year year-six sales, earnings per share guidance range unchanged.
qtrly tavr sales of $858 million, up num-two% on a reported basis.
tavr sales negatively impacted in last two months of qtr-three due to significant impact covid had on hospital resources.